Literature DB >> 29523633

MANAGEMENT OF ENDOCRINE DISEASE: Management of Cushing's syndrome during pregnancy: solved and unsolved questions.

Thierry Brue1,2, Vincent Amodru1,2, Frederic Castinetti1,2.   

Abstract

With fewer than 200 reported cases, Cushing's syndrome (CS) in pregnancy remains a diagnostic and therapeutic challenge. In normal pregnancies, misleading signs may be observed such as striae or hypokalemia, while plasma cortisol and urinary free cortisol may rise up to 2- to 3-fold. While the dexamethasone suppression test is difficult to use, reference values for salivary cortisol appear valid. Apart from gestational hypertension, differential diagnosis includes pheochromocytoma and primary aldosteronism. The predominant cause is adrenal adenoma (sometimes without decreased ACTH), rather than Cushing's disease. There are considerable imaging pitfalls in Cushing's disease. Aberrant receptors may, in rare cases, lead to increased cortisol production during pregnancy in response to HCG, LHRH, glucagon, vasopressin or after a meal. Adrenocortical carcinoma (ACC) is rare and has poor prognosis. Active CS during pregnancy is associated with a high rate of maternal complications: hypertension or preeclampsia, diabetes, fractures; more rarely, cardiac failure, psychiatric disorders, infection and maternal death. Increased fetal morbidity includes prematurity, intrauterine growth retardation and less prevalently stillbirth, spontaneous abortion, intrauterine death and hypoadrenalism. Therapy is also challenging. Milder cases can be managed conservatively by controlling comorbidities. Pituitary or adrenal surgery should ideally be performed during the second trimester and patients should then be treated for adrenal insufficiency. Experience with anticortisolic drugs is limited. Metyrapone was found to allow control of hypercortisolism, with a risk of worsening hypertension. Cabergoline may be an alternative option. The use of other drugs is not advised because of potential teratogenicity and/or lack of information. Non-hormonal (mechanical) contraception is recommended until sustained biological remission is obtained.
© 2018 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29523633     DOI: 10.1530/EJE-17-1058

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

Review 1.  Glucocorticoids in pregnancy.

Authors:  Riccardo Pofi; Jeremy W Tomlinson
Journal:  Obstet Med       Date:  2019-06-09

Review 2.  Approach to Cushing's syndrome in pregnancy: two cases of Cushing's syndrome in pregnancy and a review of the literature.

Authors:  Wei Lin; Hui-Bin Huang; Jun-Ping Wen; Neng-Ying Wang; Shuang-Yu Wang; Chen Wang; Gang Chen
Journal:  Ann Transl Med       Date:  2019-09

Review 3.  Surgical indications for pituitary tumors during pregnancy: a literature review.

Authors:  Thomas Graillon; Thomas Cuny; Frédéric Castinetti; Blandine Courbière; Marie Cousin; Frédérique Albarel; Isabelle Morange; Nicolas Bruder; Thierry Brue; Henry Dufour
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

4.  Diagnosis and treatment outcomes of Cushing's disease during pregnancy.

Authors:  Kalyani Sridharan; Jayaprakash Sahoo; Rajan Palui; Milind Patil; Sadishkumar Kamalanathan; A S Ramesh; N S Kubera
Journal:  Pituitary       Date:  2021-03-29       Impact factor: 4.107

Review 5.  Adrenal insufficiency in pregnancy: Physiology, diagnosis, management and areas for future research.

Authors:  Jessica H Lee; David J Torpy
Journal:  Rev Endocr Metab Disord       Date:  2022-07-11       Impact factor: 9.306

6.  Chronic maternal hypercortisolemia models stress-induced adverse birth outcome and altered cardiac function in newborn lambs.

Authors:  Mengchen Li; Charles E Wood; Maureen Keller-Wood
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-06-07       Impact factor: 3.210

Review 7.  Endocrine causes of hypertension in pregnancy.

Authors:  Alison H Affinati; Richard J Auchus
Journal:  Gland Surg       Date:  2020-02

8.  Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy.

Authors:  A Scutelnicu; A M Panaitescu; A M Ciobanu; N Gica; R Botezatu; G Peltecu; M L Gheorghiu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

9.  Risk of miscarriage in women with chronic diseases in Norway: A registry linkage study.

Authors:  Maria C Magnus; Nils-Halvdan Morken; Knut-Arne Wensaas; Allen J Wilcox; Siri E Håberg
Journal:  PLoS Med       Date:  2021-05-10       Impact factor: 11.613

10.  Approach to the Patient Treated with Steroidogenesis Inhibitors.

Authors:  Frederic Castinetti; Lynnette K Nieman; Martin Reincke; John Newell-Price
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.